BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8629294)

  • 1. How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation.
    Eberhard OK; Kliem V; Oldhafer K; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transplantation; 1996 May; 61(9):1345-9. PubMed ID: 8629294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
    J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
    Millis JM; Woodle ES; Piper JB; Bruce DS; Newell KA; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
    Transplantation; 1996 May; 61(9):1365-9. PubMed ID: 8629298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute steroid-resistant rejection after liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lemmens P; Lobeck H; Neuhaus P
    World J Surg; 1996 Oct; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
    Jordan ML; Shapiro R; Vivas CA; Scantlebury VP; Rhandhawa P; Carrieri G; McCauley J; Demetris AJ; Tzakis A; Fung JJ
    Transplantation; 1994 Mar; 57(6):860-5. PubMed ID: 7512293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection.
    Yamani MH; Starling RC; Pelegrin D; Platt L; Majercik M; Hobbs RE; McCarthy P; Young JB
    J Heart Lung Transplant; 2000 Apr; 19(4):337-42. PubMed ID: 10775813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation.
    Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B
    J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
    Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection.
    Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T
    Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection.
    Midtvedt K; Tafjord AB; Hartmann A; Eide TC; Holdaas H; Nordal KP; Draganov B; Sødal G; Leivestad T; Fauchald P
    Transplantation; 1996 Jul; 62(1):38-42. PubMed ID: 8693541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
    Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
    Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
    [No Abstract]   [Full Text] [Related]  

  • 16. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
    Hariharan S; Munda R; Cavallo T; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplantation; 1996 Apr; 61(8):1161-5. PubMed ID: 8610411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection.
    Morris-Stiff G; Talbot D; Balaji V; Baboolal K; Callanan K; Hails J; Moore R; Manas D; Lord R; Jurewicz WA
    Transpl Int; 1998; 11 Suppl 1():S78-81. PubMed ID: 9664949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
    Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
    Jordan ML; Naraghi R; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):223-8. PubMed ID: 9020321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.